<?xml version="1.0" encoding="utf-8"?>
<Articles JournalTitle="Iranian Journal of Public Health">
    <Article>
        <Journal>
            <PublisherName>Kowsar</PublisherName>
            <JournalTitle>Jundishapur J Microbiol</JournalTitle>
            <Issn>2008-4161</Issn>
            <Volume>11</Volume>
            <Issue>9</Issue>
            <PubDate PubStatus="epublish">
                <Year>2018</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubDate>
            <journal_id_doi>10.5812/jjm.62697</journal_id_doi>
        </Journal>
        <title locale="en_US">Emergence of &lt;i&gt;Staphylococcus epidermidis&lt;/i&gt; Clinical Isolates with Resistance to Both Mupirocin and Fusidic Acid</title>
        <AuthorList>
            <Author>
                <FirstName>Chunchan</FirstName>
                <LastName>Lin</LastName>
            </Author>
            <Author>
                <FirstName>Shuying</FirstName>
                <LastName>Chen</LastName>
            </Author>
            <Author>
                <FirstName>Ye</FirstName>
                <LastName>Jin</LastName>
            </Author>
            <Author>
                <FirstName>Jingjing</FirstName>
                <LastName>Duan</LastName>
            </Author>
            <Author>
                <FirstName>Zhihao</FirstName>
                <LastName>Hao</LastName>
            </Author>
            <Author>
                <FirstName>Shanshan</FirstName>
                <LastName>Wang</LastName>
            </Author>
            <Author>
                <FirstName>Yinjuan</FirstName>
                <LastName>Guo</LastName>
            </Author>
            <Author>
                <FirstName>Longhua</FirstName>
                <LastName>Hu</LastName>
            </Author>
            <Author>
                <FirstName>Liangxing</FirstName>
                <LastName>Wang</LastName>
            </Author>
            <Author>
                <FirstName>Fangyou</FirstName>
                <LastName>Yu</LastName>
                <affiliation locale="en_US">4Department of Laboratory Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China, Department of Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University, School of Medicine, Shanghai 200001, China</affiliation>
            </Author>
        </AuthorList>
        <ArticleType>Research Article</ArticleType>
        <History>
            <PubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubDate>
            <PubDate PubStatus="received">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>10</Day>
            </PubDate>
            <PubDate PubStatus="epublish">
                <Year>2018</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubDate>
            <PubDate PubStatus="ppublish">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>30</Day>
            </PubDate>
        </History>
        <abstract locale="en_US">Background : In the recent decades, mupirocin and fusidic acid (FA) have become important antimicrobial agents for skin and soft tissue infections (SSTIs) and the eradication of staphylococci colonization. Objectives : The present study aimed at determining the role of mupirocin and FA resistance in controlling 
        <i>Staphylococcus epidermidis</i>infections and eradication of staphylococci colonization. Methods : This study was conducted between January 2012 and December 2015, at a tertiary hospital in Wenzhou, east China, on 711 
        <i>S. epidermidis</i>clinical isolates collected consecutively from various specimens of inpatients. Polymerase chain reaction (PCR) and DNA sequencing were used to identify 
        <i>mupA</i>conferring high-level mupirocin resistance and 
        <i>fusA</i>mutations. Multi-locus sequence typing (MLST) based on nucleotide sequencing of seven housekeeping genes revealed distinct related clones of methicillin-resistant 
        <i>S. epidermidis</i>(MRSE), as clinically significant isolates. Results : Twelve FA-resistant 
        <i>S. epidermidis</i>clinical isolates were positive for 
        <i>fusB</i>, while only one was positive for 
        <i>fusC</i>. All six 
        <i>S. epidermidis</i>isolates with low-level mupirocin resistance were negative for 
        <i>mupA</i>. However, 23 (35.38%) of 65 isolates with high level of resistance to mupirocin were found to carry this gene. Surprisingly, among 31 isolates with both mupirocin and FA resistance, only two were positive for 
        <i>fusB</i>and only six were positive for 
        <i>mupA</i>. More than 50% of the resistance for 71 mupirocin-resistant isolates and 56 FA-resistant isolates to non β-lactam included erythromycin, clindamycin, ciprofloxacin, gentamicin and trimethoprim-sulfamethoxazole. Among 31 
        <i>S. epidermidis</i>isolates with both mupirocin and FA resistance, 15, three, and two belonged to ST2, ST466, and ST23, respectively. ST125 and ST130 were found in one isolate, each. All 15 ST2 
        <i>S. epidermidis</i>isolates were MRSE with high-level resistance to mupirocin (MICs &gt; 256 mg/L), with similar resistance patterns. Conclusions : Taken together, the present study is the first report of resistance to both mupirocin and FA among 
        <i>S. epidermidis</i>isolates. Dissemination of 
        <i>S. epidermidis</i>ST2 clone with both FA and mupirocin resistance can cause trouble in controlling 
        <i>S. epidermidis</i>infections and eradication of staphylococci colonization.</abstract>
        <web_url>http://jjmicrobiol.com/en/articles/62697.html</web_url>
        <pdf_url>https://cdn.neoscriber.org/cdn/dl/cd72bc24-beb8-11e8-bd3e-e7feea8aad0f</pdf_url>
    </Article>
</Articles>
